E. M. Molnar
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 13
- Drug Transport and Resistance Mechanisms 12
-
- Nanoparticle-Based Drug Delivery 5
- Co-authors
- John Tsibouklis (4 shared papers)Eugen Barbu (4 shared papers)Dariusz C. Górecki (3 shared papers)Péter Krajcsi (9 shared papers)Emese Kis (4 shared papers)Tamás Janáky (3 shared papers)Hristos Glavinas (3 shared papers)Krisztina Herédi‐Szabó (2 shared papers)
- Journals
- Biomacromolecules (2 papers)Journal of Pharmaceutical Sciences (2 papers)Thrombosis Research (2 papers)Geoforum (1 paper)Molecules (1 paper)
- Partner nations
- HungaryUnited KingdomRomania
In The Last Decade
E. M. Molnar
39 papers receiving 774 citations
Peers
Comparison fields: 5 of 97
- Pharmaceutical Science 125
- Biomaterials 167
- Oncology 296
- Pediatrics, Perinatology and Child Health 103
- Molecular Medicine 25
Countries citing papers authored by E. M. Molnar
This map shows the geographic impact of E. M. Molnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. M. Molnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. M. Molnar more than expected).
Fields of papers citing papers by E. M. Molnar
This network shows the impact of papers produced by E. M. Molnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. M. Molnar. The network helps show where E. M. Molnar may publish in the future.
Co-authors
The 25 scholars most cited alongside E. M. Molnar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 201 | |
| 2 | 2007 | 94 | |
| 3 | 2008 | 67 | |
| 4 | 2008 | 64 | |
| 5 | 2007 | 58 | |
| 6 | 2015 | 50 | |
| 7 | 2008 | 41 | |
| 8 | 2012 | 39 | |
| 9 | 2009 | 32 | |
| 10 | 2012 | 31 | |
| 11 | 2010 | 19 | |
| 12 | 2017 | 12 | |
| 13 | 2023 | 12 | |
| 14 | 2016 | 11 | |
| 15 | 2013 | 11 | |
| 16 | 2020 | 9 | |
| 17 | 2008 | 8 | |
| 18 | 2016 | 7 | |
| 19 | 2020 | 6 | |
| 20 | 2017 | 5 |
About E. M. Molnar
E. M. Molnar is a scholar working on Oncology, Biomaterials, Pediatrics, Perinatology and Child Health, Infectious Diseases and Pharmaceutical Science, having authored 47 papers that have together received 812 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (12 papers), Nanoparticle-Based Drug Delivery (5 papers), Pharmacological Effects and Toxicity Studies (4 papers), Photodynamic Therapy Research Studies (3 papers), Porphyrin and Phthalocyanine Chemistry (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Virus-based gene therapy research (3 papers) and Advanced Drug Delivery Systems (3 papers). The work is most often cited by research in Pharmaceutical Science (125 citations), Biomaterials (167 citations), Oncology (296 citations), Pediatrics, Perinatology and Child Health (103 citations) and Molecular Medicine (25 citations). E. M. Molnar has collaborated with scholars based in Hungary, United Kingdom and Romania. Frequent co-authors include John Tsibouklis, Eugen Barbu, Dariusz C. Górecki, Péter Krajcsi, Emese Kis, Tamás Janáky, Hristos Glavinas, Krisztina Herédi‐Szabó, Tünde Nagy and Lajos Szente. Their work appears in journals such as Biomacromolecules, Journal of Pharmaceutical Sciences, Thrombosis Research, Geoforum and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.